Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 59 entries
Sorted by: Best Match Show Resources per page
Serving the most severe of serious emotionally disturbed students in school settings

out of school settings

Vernberg EM, Roberts MC.
GSID: u-idK3x539cJ
JE Nyre, EM Vernberg, MC Roberts - … of School Mental Health Advancing …, 2003 - Springer

… In recognition of the significant, present, and immediate mental health needs of this nation’s children, much attention in recent years has been directed toward valuing school settings as an appropriate environment to provide access to a continuum of...

Cite
Nyre, J. E., Vernberg, E. M., & Roberts, M. C. (2003). Serving the most severe of serious emotionally disturbed students in school settings. In Handbook of School Mental Health Advancing Practice and Research (pp. 203-222). Springer, Boston, MA.
Nyre, Joseph E., Eric M. Vernberg, and Michael C. Roberts. "Serving the most severe of serious emotionally disturbed students in school settings." Handbook of School Mental Health Advancing Practice and Research. Springer, Boston, MA, 2003. 203-222.
Copy Download .nbib Format: MLA
Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study.

Journal of oral & facial pain and headache

Leksell E, Hallberg U, Horne A, Ernberg M, Hedenberg-Magnusson B.
PMID: 29019476
J Oral Facial Pain Headache. 2017;31(4):353–361. doi: 10.11607/ofph.1689. Epub 2017 Oct 10.

AIMS: To deepen knowledge of how parents of children diagnosed with juvenile idiopathic arthritis (JIA) perceive the orofacial manifestations of the disease, its treatments, and their encounters with dental care providers.METHODS: A total of 15 interviews with parents of...

Cite
Leksell E, Hallberg U, Horne A, et al. Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study. J Oral Facial Pain Headache. 2017;31(4):353–361doi: 10.11607/ofph.1689.
Leksell, E., Hallberg, U., Horne, A., Ernberg, M., & Hedenberg-Magnusson, B. (2017). Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study. Journal of oral & facial pain and headache, 31(4), 353–361. https://doi.org/10.11607/ofph.1689
Leksell, Eva, et al. "Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study." Journal of oral & facial pain and headache vol. 31,4 (2017): 353–361. doi: https://doi.org/10.11607/ofph.1689
Leksell E, Hallberg U, Horne A, Ernberg M, Hedenberg-Magnusson B. Parenting a Child with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: A Qualitative Study. J Oral Facial Pain Headache. 2017;31(4):353–361. doi: 10.11607/ofph.1689. Epub 2017 Oct 10. PMID: 29019476.
Copy Download .nbib Format: NLM
Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique.

Journal of pain research

Gerdle B, Ghafouri B, Ernberg M, Larsson B.
PMID: 24966693
J Pain Res. 2014 Jun 12;7:313-26. doi: 10.2147/JPR.S59144. eCollection 2014.

Chronic musculoskeletal pain conditions are multifaceted, and approximately 20% of the adult population lives with severe chronic pain, with a higher prevalence in women and in lower income groups. Chronic pain is influenced by and interacts with physical, emotional,...

Cite
Gerdle B, Ghafouri B, Ernberg M, et al. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res. 2014;7:313-26doi: 10.2147/JPR.S59144.
Gerdle, B., Ghafouri, B., Ernberg, M., & Larsson, B. (2014). Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. Journal of pain research, 7313-26. https://doi.org/10.2147/JPR.S59144
Gerdle, Björn, et al. "Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique." Journal of pain research vol. 7 (2014): 313-26. doi: https://doi.org/10.2147/JPR.S59144
Gerdle B, Ghafouri B, Ernberg M, Larsson B. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res. 2014 Jun 12;7:313-26. doi: 10.2147/JPR.S59144. eCollection 2014. PMID: 24966693; PMCID: PMC4062547.
Copy Download .nbib Format: NLM
QUANTITATIVE GENETICS OF JUVENILE GROWTH AND SHAPE IN THE MUD CRAB EURYPANOPEUS DEPRESSUS 1.

The Biological bulletin

Hilbish TJ, Vernberg FJ.
PMID: 29320231
Biol Bull. 1987 Dec;173(3):461-473. doi: 10.2307/1541693.

Rates of growth and development were measured for the first six molts following the crab 1 stage in the mud crab Eurypanopeus depressus. The genetic contribution to variation in growth rate, development rate, and shape was determined for each...

Cite
Hilbish TJ, Vernberg FJ. QUANTITATIVE GENETICS OF JUVENILE GROWTH AND SHAPE IN THE MUD CRAB EURYPANOPEUS DEPRESSUS 1. Biol Bull. 1987;173(3):461-473doi: 10.2307/1541693.
Hilbish, T. J., & Vernberg, F. J. (1987). QUANTITATIVE GENETICS OF JUVENILE GROWTH AND SHAPE IN THE MUD CRAB EURYPANOPEUS DEPRESSUS 1. The Biological bulletin, 173(3), 461-473. https://doi.org/10.2307/1541693
Hilbish, Thomas J, and Vernberg, F John. "QUANTITATIVE GENETICS OF JUVENILE GROWTH AND SHAPE IN THE MUD CRAB EURYPANOPEUS DEPRESSUS 1." The Biological bulletin vol. 173,3 (1987): 461-473. doi: https://doi.org/10.2307/1541693
Hilbish TJ, Vernberg FJ. QUANTITATIVE GENETICS OF JUVENILE GROWTH AND SHAPE IN THE MUD CRAB EURYPANOPEUS DEPRESSUS 1. Biol Bull. 1987 Dec;173(3):461-473. doi: 10.2307/1541693. PMID: 29320231.
Copy Download .nbib Format: NLM
Controller⁻Pilot Data Link Communication Security.

Sensors (Basel, Switzerland)

Gurtov A, Polishchuk T, Wernberg M.
PMID: 29783791
Sensors (Basel). 2018 May 20;18(5). doi: 10.3390/s18051636.

The increased utilization of the new types of cockpit communications, including controller⁻pilot data link communications (CPDLC), puts the airplane at higher risk of hacking or interference than ever before. We review the technological characteristics and properties of the CPDLC...

Cite
Gurtov A, Polishchuk T, Wernberg M. Controller⁻Pilot Data Link Communication Security. Sensors (Basel). 2018;18(5)doi: 10.3390/s18051636.
Gurtov, A., Polishchuk, T., & Wernberg, M. (2018). Controller⁻Pilot Data Link Communication Security. Sensors (Basel, Switzerland), 18(5), . https://doi.org/10.3390/s18051636
Gurtov, Andrei, et al. "Controller⁻Pilot Data Link Communication Security." Sensors (Basel, Switzerland) vol. 18,5 (2018). doi: https://doi.org/10.3390/s18051636
Gurtov A, Polishchuk T, Wernberg M. Controller⁻Pilot Data Link Communication Security. Sensors (Basel). 2018 May 20;18(5). doi: 10.3390/s18051636. PMID: 29783791; PMCID: PMC5982923.
Copy Download .nbib Format: NLM
Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients.

BJS open

Vuoristo M, Muhonen T, Koljonen V, Juteau S, Hernberg M, Ilmonen S, Jahkola T.
PMID: 34904646
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab128.

BACKGROUND: Lower limb or trunk melanoma often presents with femoral and pelvic sentinel lymph nodes (SLNs). The benefits of harvesting pelvic lymph nodes remain controversial. In this retrospective study, the frequency and predictors of pelvic SLNs (PSLNs), and the...

Cite
Vuoristo M, Muhonen T, Koljonen V, et al. Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab128.
Vuoristo, M., Muhonen, T., Koljonen, V., Juteau, S., Hernberg, M., Ilmonen, S., & Jahkola, T. (2021). Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab128
Vuoristo, Mikko, et al. "Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab128
Vuoristo M, Muhonen T, Koljonen V, Juteau S, Hernberg M, Ilmonen S, Jahkola T. Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab128. PMID: 34904646.
Copy Download .nbib Format: NLM
Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma.

Endocrine connections

Karhapää H, Mäkelä S, Laurén H, Jaakkola M, Schalin-Jäntti C, Hernberg M.
PMID: 35015699
Endocr Connect. 2022 Jan 01; doi: 10.1530/EC-21-0562. Epub 2022 Jan 01.

OBJECTIVE: Immune checkpoint inhibitors (ICI) can cause endocrine adverse events. However, endocrine AEs could be related to better treatment outcomes. Our aim was to investigate whether this holds true in a real-world setting of metastatic melanoma patients.DESIGN: A retrospective...

Cite
Karhapää H, Mäkelä S, Laurén H, et al. Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma. Endocr Connect. 2022;doi: 10.1530/EC-21-0562.
Karhapää, H., Mäkelä, S., Laurén, H., Jaakkola, M., Schalin-Jäntti, C., & Hernberg, M. (2022). Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma. Endocrine connections, . https://doi.org/10.1530/EC-21-0562
Karhapää, Hanna, et al. "Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma." Endocrine connections vol. (2022). doi: https://doi.org/10.1530/EC-21-0562
Karhapää H, Mäkelä S, Laurén H, Jaakkola M, Schalin-Jäntti C, Hernberg M. Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma. Endocr Connect. 2022 Jan 01; doi: 10.1530/EC-21-0562. Epub 2022 Jan 01. PMID: 35015699.
Copy Download .nbib Format: NLM
Seizure Severity and Treatment Response in Newborn Infants with Seizures Attributed to Intracranial Hemorrhage.

The Journal of pediatrics

Herzberg EM, Machie M, Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, Cilio MR, Bonifacio SL, Massey SL, McCulloch CE, Soul JS.
PMID: 34780777
J Pediatr. 2021 Nov 12; doi: 10.1016/j.jpeds.2021.11.012. Epub 2021 Nov 12.

OBJECTIVE: To characterize intracranial hemorrhage (ICH) as a seizure etiology in infants born at term and preterm. For term infants, to compare seizure severity and treatment response for multi-site vs single-site ICH and hypoxic-ischemic encephalopathy (HIE) with vs. without...

Cite
Herzberg EM, Machie M, Glass HC, et al. Seizure Severity and Treatment Response in Newborn Infants with Seizures Attributed to Intracranial Hemorrhage. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.11.012.
Herzberg, E. M., Machie, M., Glass, H. C., Shellhaas, R. A., Wusthoff, C. J., Chang, T., Abend, N. S., Chu, C. J., Cilio, M. R., Bonifacio, S. L., Massey, S. L., McCulloch, C. E., Soul, J. S. (2021). Seizure Severity and Treatment Response in Newborn Infants with Seizures Attributed to Intracranial Hemorrhage. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.11.012
Herzberg, Emily M, et al. "Seizure Severity and Treatment Response in Newborn Infants with Seizures Attributed to Intracranial Hemorrhage." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.11.012
Herzberg EM, Machie M, Glass HC, Shellhaas RA, Wusthoff CJ, Chang T, Abend NS, Chu CJ, Cilio MR, Bonifacio SL, Massey SL, McCulloch CE, Soul JS. Seizure Severity and Treatment Response in Newborn Infants with Seizures Attributed to Intracranial Hemorrhage. J Pediatr. 2021 Nov 12; doi: 10.1016/j.jpeds.2021.11.012. Epub 2021 Nov 12. PMID: 34780777.
Copy Download .nbib Format: NLM
Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients.

BJS open

Vuoristo M, Muhonen T, Koljonen V, Juteau S, Hernberg M, Ilmonen S, Jahkola T.
PMID: 34904646
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab128.

BACKGROUND: Lower limb or trunk melanoma often presents with femoral and pelvic sentinel lymph nodes (SLNs). The benefits of harvesting pelvic lymph nodes remain controversial. In this retrospective study, the frequency and predictors of pelvic SLNs (PSLNs), and the...

Cite
Vuoristo M, Muhonen T, Koljonen V, et al. Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab128.
Vuoristo, M., Muhonen, T., Koljonen, V., Juteau, S., Hernberg, M., Ilmonen, S., & Jahkola, T. (2021). Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab128
Vuoristo, Mikko, et al. "Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab128
Vuoristo M, Muhonen T, Koljonen V, Juteau S, Hernberg M, Ilmonen S, Jahkola T. Pelvic sentinel lymph nodes have minimal impact on survival in melanoma patients. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab128. PMID: 34904646; PMCID: PMC8669789.
Copy Download .nbib Format: NLM
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening.

Cancer discovery

Lalazar G, Requena D, Ramos-Espiritu L, Ng D, Bhola PD, de Jong YP, Wang R, Narayan NJC, Shebl B, Levin S, Michailidis E, Kabbani M, Vercauteren KOA, Hurley AM, Farber BA, Hammond WJ, Saltsman JA, Weinberg EM, Glickman JF, Lyons BA, Ellison J, Schadde E, Hertl M, Leiting JL, Truty MJ, Smoot RL, Tierney F, Kato T, Wendel HG, LaQuaglia MP, Rice CM, Letai A, Coffino P, Torbenson MS, Ortiz MV, Simon SM.
PMID: 34127480
Cancer Discov. 2021 Oct;11(10):2544-2563. doi: 10.1158/2159-8290.CD-20-0872. Epub 2021 Jun 14.

To repurpose therapeutics for fibrolamellar carcinoma (FLC), we developed and validated patient-derived xenografts (PDX) from surgical resections. Most agents used clinically and inhibitors of oncogenes overexpressed in FLC showed little efficacy on PDX. A high-throughput functional drug screen found...

Cite
Lalazar G, Requena D, Ramos-Espiritu L, et al. Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer Discov. 2021;11(10):2544-2563doi: 10.1158/2159-8290.CD-20-0872.
Lalazar, G., Requena, D., Ramos-Espiritu, L., Ng, D., Bhola, P. D., de Jong, Y. P., Wang, R., Narayan, N. J. C., Shebl, B., Levin, S., Michailidis, E., Kabbani, M., Vercauteren, K. O. A., Hurley, A. M., Farber, B. A., Hammond, W. J., Saltsman, J. A., Weinberg, E. M., Glickman, J. F., Lyons, B. A., Ellison, J., Schadde, E., Hertl, M., Leiting, J. L., Truty, M. J., Smoot, R. L., Tierney, F., Kato, T., Wendel, H. G., LaQuaglia, M. P., Rice, C. M., Letai, A., Coffino, P., Torbenson, M. S., Ortiz, M. V., & Simon, S. M. (2021). Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer discovery, 11(10), 2544-2563. https://doi.org/10.1158/2159-8290.CD-20-0872
Lalazar, Gadi, et al. "Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening." Cancer discovery vol. 11,10 (2021): 2544-2563. doi: https://doi.org/10.1158/2159-8290.CD-20-0872
Lalazar G, Requena D, Ramos-Espiritu L, Ng D, Bhola PD, de Jong YP, Wang R, Narayan NJC, Shebl B, Levin S, Michailidis E, Kabbani M, Vercauteren KOA, Hurley AM, Farber BA, Hammond WJ, Saltsman JA, Weinberg EM, Glickman JF, Lyons BA, Ellison J, Schadde E, Hertl M, Leiting JL, Truty MJ, Smoot RL, Tierney F, Kato T, Wendel HG, LaQuaglia MP, Rice CM, Letai A, Coffino P, Torbenson MS, Ortiz MV, Simon SM. Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening. Cancer Discov. 2021 Oct;11(10):2544-2563. doi: 10.1158/2159-8290.CD-20-0872. Epub 2021 Jun 14. PMID: 34127480.
Copy Download .nbib Format: NLM
High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma.

Translational oncology

Kohtamäki L, Arjama M, Mäkelä S, Ianevski P, Välimäki K, Juteau S, Ilmonen S, Ungureanu D, Kallioniemi O, Murumägi A, Hernberg M.
PMID: 34837846
Transl Oncol. 2021 Nov 24;15(1):101290. doi: 10.1016/j.tranon.2021.101290. Epub 2021 Nov 24.

Therapy options for patients with metastatic melanoma (MM) have considerably improved over the past decade. However, many patients still need effective therapy after unsuccessful immunotherapy, especially patients with BRAF-negative tumors who lack the option of targeted treatment second line....

Cite
Kohtamäki L, Arjama M, Mäkelä S, et al. High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. Transl Oncol. 2021;15(1):101290doi: 10.1016/j.tranon.2021.101290.
Kohtamäki, L., Arjama, M., Mäkelä, S., Ianevski, P., Välimäki, K., Juteau, S., Ilmonen, S., Ungureanu, D., Kallioniemi, O., Murumägi, A., & Hernberg, M. (2021). High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. Translational oncology, 15(1), 101290. https://doi.org/10.1016/j.tranon.2021.101290
Kohtamäki, Laura, et al. "High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma." Translational oncology vol. 15,1 (2021): 101290. doi: https://doi.org/10.1016/j.tranon.2021.101290
Kohtamäki L, Arjama M, Mäkelä S, Ianevski P, Välimäki K, Juteau S, Ilmonen S, Ungureanu D, Kallioniemi O, Murumägi A, Hernberg M. High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma. Transl Oncol. 2021 Nov 24;15(1):101290. doi: 10.1016/j.tranon.2021.101290. Epub 2021 Nov 24. PMID: 34837846.
Copy Download .nbib Format: NLM
Photochemistry and photophysics of cholesta-5,7,9(11)-trien-3β-ol: a fluorescent analogue of cholesterol.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology

Saltiel J, Krishnan SB, Gupta S, Hernberg EA, Clark RJ.
PMID: 35000147
Photochem Photobiol Sci. 2022 Jan 09; doi: 10.1007/s43630-021-00131-w. Epub 2022 Jan 09.

Cholesta-5,7,9(11)-trien-3β-ol (9,11-dehydroprovitamin D

Cite
Saltiel J, Krishnan SB, Gupta S, et al. Photochemistry and photophysics of cholesta-5,7,9(11)-trien-3β-ol: a fluorescent analogue of cholesterol. Photochem Photobiol Sci. 2022;doi: 10.1007/s43630-021-00131-w.
Saltiel, J., Krishnan, S. B., Gupta, S., Hernberg, E. A., & Clark, R. J. (2022). Photochemistry and photophysics of cholesta-5,7,9(11)-trien-3β-ol: a fluorescent analogue of cholesterol. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, . https://doi.org/10.1007/s43630-021-00131-w
Saltiel, Jack, et al. "Photochemistry and photophysics of cholesta-5,7,9(11)-trien-3β-ol: a fluorescent analogue of cholesterol." Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology vol. (2022). doi: https://doi.org/10.1007/s43630-021-00131-w
Saltiel J, Krishnan SB, Gupta S, Hernberg EA, Clark RJ. Photochemistry and photophysics of cholesta-5,7,9(11)-trien-3β-ol: a fluorescent analogue of cholesterol. Photochem Photobiol Sci. 2022 Jan 09; doi: 10.1007/s43630-021-00131-w. Epub 2022 Jan 09. PMID: 35000147.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 59 entries